ICAM1 and coronary artery disorder: More importantly, lncRNA-FA2H-2 negatively correlated with MCP-1, VCAM-1, ICAM-1, and IL-6, further confirming the potential of lncRNA-FA2H-2 as an inflammatory biomarker in CHD patients.